EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Guidelines for the design and presentation of drug dosage forms Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Drug Distribution



Guidelines for the design and presentation of drug dosage forms Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Drug Distribution



Australian Journal of Hospital Pharmacy 22(4): 323-327




(PDF emailed within 1 workday: $29.90)

Accession: 031630107

Download citation: RISBibTeXText



Related references

SHPA position statement on the provision of drug utilisation data The Society of Hospital Pharmacists of Australia committee of specialty practices in drug usage evaluation. Australian Journal of Hospital Pharmacy 26(2): 247, 1996

SHPA guidelines of practice for aseptic dispensing services The society of hospital pharmacists of Australia Committee of Specialty Practice in Parenteral Services. Australian Journal of Hospital Pharmacy 24(6): 509-512, 1994

Shpa policy guidelines for the standard of practice of selected clinical pharmacy activities part 5 the society of hospital pharmacists of australia committee of specialty practice in clinical pharmacy adelaide south australia australia june 17 18 1988. Australian Journal of Hospital Pharmacy 20(3): 248-249, 1990

Bio-pharmaceutics II Pharmacokinetics Exponential drug disappearance biological half life factors influencing blood concentrations use of tissue concentration data in design of dosage forms and dosage regimens evaluation of drugs and drug products. Amer J Pharm: 175-193, 1965

Practice guidelines--disorders of lipid metabolism. From recommendations to therapy of disorders of lipid metabolism by the Drug Committee of the German Medical Society. Drug Committee of the German Medical Society. Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 94(1): 61-64, 2000

Polymer-drug interacted systems in the physicochemical design of pharmaceutical dosage forms. I. Drug salts with PVM-MA and with a PVM-MA hemi-ester. Journal of Pharmaceutical Sciences 57(9): 1598-1603, 1968

Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing. Journal of Controlled Release 268: 40-48, 2017

ASHP guidelines on clinical drug research. American Society of Health-System Pharmacists. American Journal of Health-System Pharmacy 55(4): 369-375, 1998

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 104(17): 2118-2150, 2001

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. European Heart Journal 22(20): 1852-1923, 2001

Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists. American Journal of Health-System Pharmacy 66(24 Suppl 7): S13-S20, 2010

Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee. Medical Journal of Australia 164(10): 589-592, 1996

Guidelines for pharmacists and the pharmaceutical industry. The Canadian Society of Hospital Pharmacists. Dimensions in Health Service 67(8): 14-16, 1990

A survey of adverse drug reaction reporting by hospital pharmacists to the Committee on Safety of Medicines the role of pharmacy departments. International Journal of Pharmacy Practice 7(3): 167-171, 1999

Socialist management science in drug and pharmaceutical organizations. 30. Specialty-specific drug assortments in stationary health facilities as a factor in scientifically based drug therapy and as an hypothesis for the evaluation of drug requirements by means of automatic data processing. 2. Initial experiences in the elaboration and testing of specialty specific drug assortments, which can be evaluated using ADP. Pharmazeutische Praxis 2: Suppl 2:39-46, 1973